Support in USA : 1-978- 707-9553 / Support in India : +91- 9987711567

  • Apple Pharmaceuticals

Velpanat - 12 weeks


Availability: In stock

Special Price $ 1699

BRAND : Velpanat
STRENGTH : 400 mg & 100 mg
INGREDIENT : HepatitisC-Natco-Velpatasvir-100mg-Sofosbuvir-400mg-Velpanat
COUNT : 28 Tablets

Description of Velpanat - 12 weeks


Velpanat is a combination of two prime anti-viral medications which is used for the treatment of chronic hepatitis C virus infection

Drug Description:

Generic: Epclusa
Drug Name: Velpatasvir and Sofosbuvir
Strength of the drug: Velpatasvir 100mg and Sofosbuvir 400mg
Manufactured by : Natco Pharma Limited

Container : 28 tablets

Velpanat (Sofosbuvir and Velpatasvir): This helps to anticipate hepatitis C virus (HCV) from replication.


Velpanat is a brand, usually it is a prescription medicine used only for adult patient who are suffered with chronic (lasting a long time) hepatitis C genotype I, II, III, IV, V or VI infection with or without cirrhosis (compensated).

Patient with advanced cirrhosis (decompensated), in this condition Velpanat is combined with ribavirin.

Pharmacology of Velpanat - 12 weeks

Indication of Velpanat - 12 weeks

Dose & Dosage's of Velpanat - 12 weeks


Velpanat is administered with or without food.

Side Effects of Velpanat - 12 weeks

Desirable side effects:

1. Headache

2. Tiredness

In advanced cirrhosis, patient taking Velpanat with ribavirin in the condition they attain some common side effects includes anemia, nausea, insomnia, and diarrhea.

Contraindication of Velpanat - 12 weeks

Drug Interaction of Velpanat - 12 weeks

Precaution of Velpanat - 12 weeks

Usage & Safety profile of Velpanat - 12 weeks Pregnancy & Lactation

Storage of Velpanat - 12 weeks

Storage condition:

Store at below 30 °C (86 °F).
Medicine will dispense only in original container.